HANNAH MASON: Open Payments
NPI 1043759319 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 20 payments from 14 companies in 2025. Trend: 2023 $806 · 2024 $735 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| HARMONY BIOSCIENCES LLC | 1 | $40 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| JAZZ PHARMACEUTICALS INC. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $15 |
Products named: Kerendia, WAKIX, UBRELVY, TRELEGY ELLIPTA, Auvelity, XYWAV, LINZESS, CAPLYTA.
Industry payments across IN — which companies pay providers there.
